ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-80.49M
↓ 35% below average
Average (3y)
$-59.58M
Historical baseline
Range
High:$-36.91M
Low:$-80.49M
CAGR
+16.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-80.49M | -16.1% |
| 2023 | $-69.33M | -87.9% |
| 2022 | $-36.91M | +28.5% |
| 2021 | $-51.61M | - |